Provided by Tiger Trade Technology Pte. Ltd.

Neurocrine Biosciences

156.76
+2.731.77%
Post-market: 158.531.77+1.13%17:43 EDT
Volume:878.42K
Turnover:137.12M
Market Cap:15.99B
PE:22.98
High:157.03
Open:154.31
Low:153.70
Close:154.03
52wk High:186.12
52wk Low:122.14
Shares:102.00M
Float Shares:100.00M
Volume Ratio:0.81
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):6.82
EPS(LYR):4.67
ROE:22.09%
ROA:11.70%
PB:4.33
PE(LYR):33.57

Loading ...

Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Oct 31, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2023

Major Issues Report

Form 8-K - Current report
Oct 06, 2023

Major Issues Report

Form 8-K - Current report
Oct 05, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities